Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " August 04, 2010":" September 03, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 04, 2010":" September 03, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Could Dietary Algae Affect Immunity and Viral Counts in People With HIV?
Condition: HIV Infections
Intervention: Other: seaweed, spirulina, seaweed + spirulina
2 Completed
Has Results
Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients
Condition: HIV Infections
Intervention:
3 Terminated Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
Conditions: HIV Infection;   Mitochondrial Dysfunction
Interventions: Drug: Atazanavir/ritonavir;   Drug: Efavirenz
4 Unknown  A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
Conditions: HIV Infection;   Gastrointestinal Symptoms
Interventions: Dietary Supplement: GanedenBC30, GBI-30, PTA-6086;   Drug: Placebo
5 Completed
Has Results
Atripla to Raltegravir Switch Study for CNS Toxicity
Condition: HIV Infection
Intervention: Drug: Truvada/Raltegravir
6 Completed PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
Condition: HIV Infection
Intervention: Drug: Maraviroc
7 Completed Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
8 Completed Development of an Empowerment Intervention for Young Women Living With HIV
Condition: HIV
Intervention: Behavioral: Evolution: Young Women Taking Charge and Growing Stronger
9 Completed Evaluating Factors That Impact Loss to Follow-up Among Postpartum HIV-infected Women in Mississippi
Condition: HIV
Intervention:
10 Completed The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance
Conditions: HIV-infection;   Pregnancy;   Mother to Child Transmission
Intervention: Drug: phenytoin
11 Completed KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
Condition: Antiretroviral Therapy in HIV-1 Infected Children
Interventions: Drug: Kaletra dosed once daily;   Drug: kaletra dosed twice daily
12 Terminated Study on Interleukin-7 (CYT107) in HIV Patients
Condition: HIV
Intervention: Biological: Interleukin-7
13 Completed Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
Condition: HIV
Intervention: Behavioral: Health System Navigator
14 Completed Russian Labor Migrant HIV Prevention Trial
Condition: HIV
Intervention: Behavioral: Social Network Intervention
15 Completed
Has Results
A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Conditions: Hepatitis C Infection;   HIV Infection
Intervention: Drug: Nitazoxanide With Pegylated Interferon And Ribavirin
16 Completed Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
Condition: Human Immunodeficiency Virus
Interventions: Drug: tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV);   Drug: tenofovir/emtricitabine (TDF/FTC);   Drug: Atazanavir (ATV);   Drug: Ritonavir;   Procedure: Phlebotomy
17 Active, not recruiting Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Condition: HIV-1
Intervention: Genetic: OZ1 transduced cells
18 Terminated A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: YASMIN;   Drug: GSK2248761;   Other: Placebo
19 Completed Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Circumcision, Male;   Patient Compliance;   Cellular Phone
Intervention: Other: Text Message
20 Completed HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Conditions: HIV;   Sexually Transmitted Diseases
Interventions: Behavioral: STYLEnS;   Behavioral: Health Promotion

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.